Skip to main content

Table 3 Single-sample GSVA analysis on EGFR-containing gene sets

From: Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial

Gene Set

EGFR subgroupsa

Mean GSVA score

P-valueb

(nomenclature reported in Fig. 3A)

A

Bc

A

B

GOBP_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY

(EGFR_signaling_pathway) (113) {123]d

0

M

-0,0288

-0,0162

0,588

0

MM

-0,0288

0,1576

0,007

M

MM

-0,0162

0,1576

0,009

GOBP_NEGATIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY

(Negative_regulation_of_ERBB) (47) [53]

0

M

-0.0049

0.0042

0.783

0

MM

-0.0049

0.1789

0.024

M

MM

0.0042

0.1789

0.028

GOBP_REGULATION_OF_ERBB_SIGNALING_PATHWAY

(Regulation_of_ERBB) (87) [96]

0

M

-0,0195

-0,0151

0,857

0

MM

-0,0195

0,1605

0,0003

M

MM

-0,0151

0,1605

0,0002

GOBP_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR

(EGF_response) (44) [46]

0

M

0,0001

-0,0067

0,84

0

MM

0,0001

0,1768

0,038

M

MM

-0,0067

0,1768

0,033

GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY

(TRPK_activity) (79) [80]

0

M

-0,059

-0,0287

0,178

0

MM

-0,059

0,1569

0,018

M

MM

-0,0287

0,1569

0,03

GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY

(TRPTK_activity) (60) [61]

0

M

-0,0667

-0,0456

0,348

0

MM

-0,0667

0,1309

0,032

M

MM

-0,0456

0,1309

0,046

  1. aEGFR-expressing: M0, EGFR negative; M, 30% EGFR membrane expression; MM, 100% EGFR expression
  2. bIn bold significant different p values by Student’s t test
  3. cA and B indicate the group comparison and the relative GSVA scores
  4. d()number of genes present in the MITO16A dataset; [] number of genes in the genesetsÂ